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Abstract
Obtaining an in-depth understanding of the arms races between peptides comprising the innate immune response and
bacterial pathogens is of fundamental interest and will inform the development of new antibacterial therapeutics. We
investigated whether a whole organism view of antimicrobial peptide (AMP) challenge on Escherichia coli would provide a
suitably sophisticated bacterial perspective on AMP mechanism of action. Selecting structurally and physically related AMPs
but with expected differences in bactericidal strategy, we monitored changes in bacterial metabolomes, morphological
features and gene expression following AMP challenge at sub-lethal concentrations. For each technique, the vast majority of
changes were specific to each AMP, with such a plastic response indicating E. coli is highly capable of discriminating
between specific antibiotic challenges. Analysis of the ontological profiles generated from the transcriptomic analyses
suggests this approach can accurately predict the antibacterial mode of action, providing a fresh, novel perspective for
previous functional and biophysical studies.
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Introduction
The isolation of cecropins [1], magainins [2] and defensins [3]
from insects, amphibians and mammals in the late 1980’s and early
1990’s, highlighted the potential of host defence peptides as sources
of novel antibiotics [4]. This novel antibiotic potential encouraged
researchers to develop structure activity relationships for cationic
antimicrobial peptides (AMPs), with the anionic bacterial plasma
membrane the presumed site of action for bactericidal activity [5].
There is increasing evidence however that each AMP may indeed
have multiple effects on a bacterial cell and hence may have multiple
ways of killing microbial targets. AMPs may therefore function as
‘‘dirty drugs’’ with different bactericidal strategies possible for distinct
bacterial species [4–7]. Indeed, the innate immune system may have
selected AMPs that can exert their antimicrobial activity in multiple
ways since this is less likely to lead to resistance developing as seen
with classical antibiotics that have a single, high affinity target [6].
Our understanding of how AMPs function is therefore far from
complete. Attempts to optimize AMP potency in the laboratory, that
focus on only one possible bactericidal mechanism, ignore the
possibilities offered by taking a holistic approach that can reveal the
true source(s) of bactericidal potency along with a better under-
standing of bacterial counter-measures.
The full power of ‘omics based research tools has yet to be
brought to bear in antibiotic research [8]. Nevertheless, important
insights have emerged regarding the scope of bacterial responses
by comparing challenges with distinct AMPs [8]. These studies
have focussed on the Gram-positive bacterial species Bacillus subtilis
[9], Staphylococcus aureus [10] and Streptococcus pneumoniae [11] and
have demonstrated the existence of complex regulatory patterns in
which several signal transduction pathways were induced. The
transcriptional response of Escherichia coli to cecropin A, the proline
rich Bac7(1-35) and novispirin G10 has been characterised in
separate studies [12–14]. Recent work in our laboratory has
focussed on trying to understand the relative difference in
antibacterial potency of structurally related AMPs to Gram-
negative bacteria such as Escherichia coli and Pseudomonas aeruginosa
[15–18]. Here, AMPs with structural features thought to enhance
antibacterial potency and reduce toxicity have been developed for
use against more challenging pathogens [19,20]. These peptides,
including D-LAK120-AP13, have been developed based on an
understanding of a variety of naturally occurring peptides
including magainin 2, buforin II and pleurocidin. Pleurocidin is
a 25 amino acid AMP found in the skin and gills of Pleuronectes
americanus, the Winter Flounder. Despite resembling magainin 2 in
terms of length, cationic charge, hydrophobicity and secondary
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structure in a range of membrane mimetic environments [18],
pleurocidin is typically ten times more potent against Gram-
negative species. Pleurocidin has been shown to be capable of
acting on bacterial membranes [21], with pore forming activity,
but has also been suggested to enter bacterial cells and interrupt
protein synthesis [22]. We have therefore compared its effect on E.
coli with magainin 2, which has been considered the archetypal
pore forming AMP, and with buforin II which is proposed to enter
bacteria to exert a bactericidal effect [23,24].
Since these peptides act at widely differing effective concentra-
tions we hypothesised that studying their effects at sub-lethal
concentrations would provide a detailed overview of the mecha-
nisms of action of each AMP. We therefore devised a method that
could efficiently identify conditions where bacteria responded to
AMP challenge without introducing possible, non-specific com-
plications that might result from large scale cell death. We
therefore used 1H high resolution magic angle spinning (HR-
MAS) NMR to identify the lowest AMP concentration that elicited
a response from metabolically active, challenged bacteria. A
robust, cross-validated, multivariate analysis identified metabolites
whose levels were altered in response to AMP challenge. These
were used to classify the AMP according to the elicited response
whilst providing a first indication of whether E. coli responded in a
generic or specific manner to AMP challenge. Having identified
sub-lethal conditions where a response was confirmed, electron
microscopy and transcript profile analyses enabled a detailed
description of the E. coli response to AMP challenge.
Results
1H HR-MAS NMR metabolomics reveals threshold
AMP concentration inducing a bacterial response –The
four cationic amphipathic AMPS selected to test the response of
stationary phase E. coli (Table 1) were of similar length and were
all C-terminally amidated with nominal charge ranging from +4 to
+9. For the AMP challenge experiments presented here, higher
bacterial cell densities (86108 CFU/ml) were required than is
common in the broth microdilution assays [25] used to generate
Author Summary
Antimicrobial peptides (AMP) are small proteins with often
potent antibacterial activity found in a variety of organ-
isms, including humans. Understanding how these antibi-
otics operate is challenging and often controversial since
many studies have necessarily focussed on identifying a
single major cause of bacterial cell death while, increas-
ingly, others have cautioned that AMPs are likely to have
access to multiple bactericidal features. Systems biology is
an emerging field that comprises a series of techniques
capable of giving a global view of how bacteria respond to
external stimuli. Here we have monitored changes in gene
expression and metabolism in bacteria that have been
challenged with sub-lethal concentrations of four different
AMPs. By understanding how bacteria respond to a threat
we can reveal how the bacteria perceive the AMP to be
operating. Our approach provides a sophisticated bacterial
perspective of the mode of action of each AMP and reveals
that the bacteria have a vast array of weapons that can be
marshalled to deal with distinct AMP threats. Indeed,
around a third (or even more) of the bacterial machinery
might be useful in dealing with antibiotic challenges,
highlighting why antibiotic resistance is such a persistent
problem.
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the MIC data (Table 1), in particular for HR-MAS analysis. At the
higher bacterial titre, although the relative potency is similar, the
effect of the four AMPs determined using such methods was
somewhat different from the minimum inhibitory concentrations
(MICs), with D-LAK120-AP13 having a substantially greater
effect on bacterial numbers as detected in the challenge and
recovery assay (Fig. 1A). Neither magainin 2 nor buforin II had a
sufficiently inhibitory effect for a MIC to be determined at the
higher titre. Nevertheless the amount of peptide causing a
significant reduction in bacterial re-growth can be compared with
D-LAK120AP13 effective at 15.6 mg/ml with substantially more
pleurocidin (62.5 mg/ml) and magainin 2 (125 mg/ml) required for
a significant effect. No effect on bacterial re-growth was observed
for buforin II at any of the peptide concentrations tested (Fig. 1A).
A multi-parameter assay was taken to assess the effect of peptide
challenge on membrane potential (Fig. 1B), esterase activity
(Fig. 1C) and membrane integrity in the challenged stationary
phase bacteria and suggested that only the higher concentrations
of pleurocidin and D-LAK120-AP13 were lethal. A dose
dependent response to each of the four AMPs was observed but
the membrane potential was not completely lost while the esterase
activity was mostly higher than that observed in untreated cells; a
hallmark of exposure to sublethal stress in E. coli [26].
One dimensional 1H NMR spectra were obtained for all
samples. Principal component analysis identified outlier spectra
resulting from either poor baseline or signal to noise, and either
partial least squares (PLS) regression analysis or a series of
orthogonal PLS-discriminant analysis (OPLS-DA) tests were used
to interrogate the spectra. The latter was used in a step-wise
manner to determine the lowest concentration of each AMP that
caused a significant change in the spectra relative to spectra from
untreated bacterial cell, as determined from Q2 (Table 2) where an
arbitrary value $0.6 was taken to show a reliable model where the
AMP challenge has a significant effect. This value can be
compared with the value expected for a perfect separation of the
two groups (Q2= 1) and that obtained when the assigned classes
(untreated or AMP challenged) are permutated as a means of
representing no effect. 2D scores plots that resulted from each of
the cross validated OPLS-DA analyses are shown in the
supplementary material (Fig. S1 in File S1) while those for the
threshold concentrations (data for the highest AMP concentration
is shown for buforin II) are described here (Fig. 2A–D). A clear
separation of the OPLS-DA scores was obtained at the indicated
AMP concentration, identified as a threshold for a response
detectable in the bacterial metabolomes. This threshold concen-
tration varied considerably for the four AMPs and was directly
related to the apparent antibacterial efficacy noted above. The
threshold value, in turn, corresponded to a sub-lethal AMP
concentration since bacterial growth remained greater than 50%
of maximum (Fig. 1A), esterase activity was increased relative to
untreated cells (Fig. 1C) while membrane potential was not
completely lost (Fig. 1B). Hence the NMR metabolomic technique
identified conditions where metabolically active E. coli were
responding to the AMP challenge without simply reporting on
bacterial cell death. Comparing the back-scaled loadings, each of
the OPLS-DA comparisons between untreated bacteria and those
challenged with each AMP, identified metabolites whose differing
intensities correlated with the effect of each AMP. A hierarchical
cluster analysis was used to reveal variation in metabolite levels
(Fig. 2E). Both common and AMP specific variations in E. coli
metabolite levels were observed in response to challenge with the
four AMPs. Notably, the hierarchical analysis grouped the
peptides according to their potency. Though not considering the
magnitude or direction of changes in metabolite levels, network
Figure 1. AMP challenge and multi-parameter assay of E. coli
NCTC 9001. Overnight cultures were challenged with increasing
amounts of each of four AMPs for 30 minutes and the recovery of
aliquots added to fresh media was measured after 4 hours incubation
at 37uC (A). * indicates the peptide concentration causing a significant
(p,0.1) reduction in OD620 relative to the lowest peptide concentration
used. The membrane potential (B) of challenged bacteria as measured
by the voltage sensitive dye DiBAC4 is expressed here as a percentage
of the membrane potential determined for untreated cells. Esterase
activity (C) determined by cleavage of 5,6-carboxyfluorescein diacetate
expressed as a percentage of the maximum observed activity. Peptide
concentrations are given in mg/ml.
doi:10.1371/journal.ppat.1004104.g001
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pathway analysis conducted using MetaboAnalyst [27,28]
matched pathways according to p-values obtained from pathway
enrichment analysis and pathway impact from pathway topology
(Fig. S2.1–S2.4 in File S1). Changes in alanine, aspartate and
glutamate metabolism had the greatest impact and were a
common feature of challenge with all four peptides with changes
in pyruvate, butanoate and arginine/proline metabolism high-
lighted according to the distinct challenges.
The dynamic response of E. coli NCTC9001 to challenge with
pleurocidin or magainin 2 was assessed over a period of 2 hours at
the following intervals: 5 minutes, 15 minutes, 60 minutes and
120 minutes. The OPLS-DA scores plots (Fig. S3 in File S1) and
corresponding Q2 (Table S1 in File S1) indicate that a response to
AMP challenge at the level of the metabolome can be detected
throughout the period tested. However, when the back-scaled
loadings were compared in a hierarchical cluster analysis (Fig. S4
in File S1), modest but notable differences in the affected
metabolites were discerned. This suggested that the bacterial
response detected beyond an hour after challenge is characteris-
tically distinct from that probed within the first 30 minutes. These
conditions – 30 minutes incubation at the determined threshold
concentration - were therefore used for subsequent electron
microscopic and transcript profiling analyses of samples prepared
in parallel to those used above.
Scanning and transmission electron microscopy
identifies differences in the response to each AMP
Changes in E. coli internal or external morphology in response
to challenge with AMP were monitored respectively using
transmission and scanning electron microscopy (TEM/SEM) at
either one or four times the sub-inhibitory AMP threshold
concentration known to induce a metabolomic response (Fig. 3;
Fig. S5.1–5.10 in File S1). The bacterial response to each AMP
challenge varied considerably and was in qualitative agreement
with the metabolomic study; buforin II had no noticeable effect
when compared with untreated bacterial cell controls (Fig. 3D–F;
Fig. S5.2/5.9/5.10 in File S1), with each of the three other AMPS
inducing substantial changes to external and/or internal mor-
phologies. For magainin 2, a regular, almost circular nucleoid
condensation was observed in some, but not all, cells (Fig. 3A; Fig.
S5.8 in File S1) while some impairment of cell division was evident
with extended rods observed (Fig. 3G). Pleurocidin also induced
nucleoid condensation but this was much more widespread;
observed throughout the bacterial cell population (Fig. S4.5/S4.6
in File S1). This was accompanied by some possible protein
aggregation and the production of large amounts of a fibrous
material (Fig. 3B). In addition to the production of the fibrous
material, SEM indentified moderate vesicle production, a known
envelope stress response in Gram-negative bacteria [29]. Finally,
D-LAK120-AP13 induced dramatic changes in both the internal
(Fig. 3C) and external E. coli morphologies (Fig. 3I). Extensive
release of outer membrane vesicles was evident which was
coincident with a loss of the normal rod shape, consistent with
bacteria budding prematurely (Fig. 3I). Inside bacterial cells,
extensive nucleoid condensation and protein aggregation was
observed throughout the bacterial cell population (Fig. 3C; Fig.
S5.3/S5.4 in File S1). Taken together, although there were some
qualitative similarities in the response of E. coli cells to each of the
three more potent AMPs, markedly distinct responses to each
peptide were observed overall. Transmission electron micrographs
obtained at higher magnification and with AMP added at a
concentration above the detected threshold value indicated that,
for all four peptides, the bacterial envelope remained intact and no
release of cell contents was apparent (Fig. S5.1 in File S1).
Global transcriptome response identifies some generic,
but largely AMP specific, responses
The response of E. coli to challenge with the four AMPs was
then probed at the level of the transcriptome. Transcript profile
changes in the NCTC 9001 strain, a clinical isolate from a patient
with cystitis with cystitis, were monitored using the E. coli Genome
2.0 Array where four strains including laboratory, uropathogenic
and enteropathogenic strains are featured. Due to the high degree
of similarity between strains, in the majority of cases, a single
probe set represents the equivalent ortholog in all four strains. All
genes that are subsequently described in detail are found in both
laboratory (K12 substr. MG1655) and uropathogenic (CFT073)
strains with the majority also found in the two enteropathogenic
strains. Principal component analysis of the twenty most differen-
tially expressed genes across all groups showed the three
independent replicates of each condition clustered together
indicating the AMP challenge and transcript profiling assay were
reproducible (Fig. S6 in File S1). Further analysis, where either an
arbitrary significance level (p#0.05) for differential gene expression
or manual manipulation of significance levels leading to an
optimal separation by principal components, generated lists of
differentially expressed genes related to each treatment. E. coli
genomes commonly encode between approximately 4,200 and
5,500 protein coding genes [30,31]. Of the approximately 10,000
probe positions, between 139 and 632 differentially expressed
unique genes (p#0.05) were detected for each treatment following
challenge with AMP at the threshold concentration eliciting a
bacterial response. This corresponds to 2.5–15.0% of the available
genome. Magainin 2 induced differential expression of only 139
Table 2. Predictive Q2 values for OPLS-DA models.
[AMP] (mg/ml) Q
2
Pleurocidin Magainin 2 Buforin II D-LAK120-AP13
3.9 0.32 (20.29) n.d n.d. 0.37 (20.30)
15.6 0.53 (20.31) 0.29 (20.36) n.d. 0.59 (20.28)*
62.5 0.81 (20.41)* 0.20 (20.31) n.d. 0.81 (20.31)
125 0.80 (20.29) 0.68 (20.34)* n.d. 0.83 (20.26)
250 n.d. n.d. 20.30 (20.39)* n.d.
Q2 values for cross validation performed with permutated classes are provided in parentheses.
* Key minimum concentrations.
doi:10.1371/journal.ppat.1004104.t002
Systems View of AMP Challenge in Escherichia coli
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Figure 2. Metabolomic analysis by 1H HR-MAS NMR of lyophilised, stationary phase E. coli cell pellets. OPLS-DA scores plots are shown
for challenge of E. coli NCTC 9001 at the following threshold concentrations; pleurocidin at 62.5 mg/ml (A), magainin 2 at 125 mg/ml (B), D-LAK120-
AP13 at 15.6 mg/ml (C) and buforin II at 250 mg/ml (D). Hierachical clustered heatmap comparing loadings obtained from cross-validated OPLS-DA
comparing untreated bacteria with AMP at the threshold concentrations indicated above (E).
doi:10.1371/journal.ppat.1004104.g002
Systems View of AMP Challenge in Escherichia coli
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genes which contrasted with the much greater number of genes
whose expression was altered in response to challenge with either
buforin II or D-LAK120-AP13; 625 and 632 respectively. Pleur-
ocidin induced differential expression of 298 genes. The distribution
of differentially expressed genes according to each AMP treatment is
represented in a Venn diagram and reveals that the vast majority
(76.3%) are specific to each of the four AMP challenges (Fig. 4A).
Only 32 differentially expressed genes, 2.4% of the total, were
common to at least three treatments while there was only one, yjjB,
which was common to all four treatments. Qualitatively therefore,
transcriptomic data supported the electron microscopy findings as,
while common responses can be identified, the dominant impression
was of a largely specific response to each AMP challenge
Mapping those discriminating metabolite changes with most
impact (Fig. S2.1–S2.4 in File S1) onto their respective Kyoto
Encyclopaedia of Genes and Genomes (KEGG) pathways
identified differentially expressed genes with a potentially key role
in mediating the response to AMP challenge. Changes in alanine,
aspartate and glutamate metabolism were common to all four
peptides and changes in expression of gltX, dapA and metB, coding
for respectively glutamyl-tRNA synthetase, dihydropicolinate
synthase and cystathionine gamma-synthase, were observed in
the gene lists though these did not always satisfy the significance
thresholds used above. Knockout mutants of dapA and gltX are not
available from the Keio collection but DmetB and five other
knockout mutants (DcyoA, DcyoC, DcyoD, DspeB, and DargR coding
respectively for cytochrome o uniquinol oxidase subunits II, III
and IV, agmatinase and arginine repressor), linked to changes in
arginine/proline metabolism, were tested for altered sensitivity to
AMP challenge though none was found.
Figure 3. Electron microscopic analysis of E. coli response to AMP challenge. Transmission (A–E) and scanning (F–I) electron micrographs at
625,000 magnification of either untreated (E/F) or AMP challenged E. coli NCTC 9001. Stationary phase bacteria were challenged for 30 minutes with
AMPs above the threshold concentration that elicits a bacterial response as determined by the 1H NMR metabolomic study; 250 mg/ml magainin 2
(A/G), 125 mg/ml pleurocidin (B/H), 62.5 mg/ml D-LAK120-AP13 (C/I) and 250 mg/ml buforin II (D). Red arrows indicate features described in the
results.
doi:10.1371/journal.ppat.1004104.g003
Systems View of AMP Challenge in Escherichia coli
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Up-regulated in response to challenge by all four AMPs, yjjB,
encodes a 157 amino acid, conserved, inner membrane protein
predicted to have four trans-membrane helices but with no known
function. Of the five genes whose expression was generically
affected by the three AMPs of natural origin, three were up-
regulated in response to AMP challenge; manA codes for mannose-
6-phosphate isomerise, cysE codes for a serine acetyltransferase
and yohN codes for a 112 amino acid integral membrane protein
annotated and established as a periplasmic modulator of nickel
and cobalt efflux and renamed rcnB [32]. In contrast, yejF, part of
an ABC transporter identified as a possible nickel, and probable
microcin C transporter [33], and yrdB, which codes for a highly
anionic, glutamine rich, 85 amino acid hypothetical protein from
the DUF1488 superfamily, are down-regulated. Comparison of
the growth of parent strain BW25113 and four knockout mutants
(DyejF, DyjjB, DyohN and DyrdB) obtained from the Keio collection
[34] confirmed yohN confers sensitivity to Co2+ and possibly Ni2+
(Fig. S7 in File S1). The growth of these strains was also tested in
the presence of AMPs (Fig. 4B). While the MIC for pleurocidin
was not affected by the presence of any of the four deletions, a
modest but significant (p,0.05) increase in sensitivity was observed
for all four deletion strains when challenged by magainin 2. When
the experiment was repeated with LL-37, an AMP of human
origin, three of the deletions rendered the bacteria more sensitive
while deletion of yrdB had no effect.
The ontological profile related to each challenge offers another
view of how closely related the response to each AMP is to each
other. Here, instead of comparing individual genes on the basis of
their identity, the comparison is based on the cellular component,
biological process or molecular function and is less affected by
redundancy or more subtle changes in response and consequently
better reflects the fundamentals of the bacterial response.
Ontological analysis, which employed a Benjamini-Hochberg
method to control false discovery rate (FDR) and displays
statistically overrepresented, differentially expressed genes in a
graphical format according to their relationships in a hierarchical
tree, was carried out on gene lists comprising the 200–250 most
differentially expressed genes for each of the individual AMP
treatments (Fig. S8–S13 in File S1) and for comparisons of up to
three AMP treatments (Fig. 5; Fig. S8/S9 in File S1). The three
AMPs derived from natural sources are suspected of acting on
different cellular components. Indeed, comparing gene ontology
(GO) term enrichment for cellular components (Fig. 5) showed a
very different profile for each of magainin 2, buforin II and
pleurocidin. Magainin 2 appears confined to affecting membrane
components (Fig. 5; Fig. S10 in File S1) and had little effect on
molecular functions or biological processes. Buforin II, in contrast,
did not impact on any membrane components, instead focussing
on components in the ‘‘cell’’ or ‘‘cell part’’ (Fig. 5; Fig. S11A in
File S1) where 41% of the differentially expressed genes related to
binding are found in the analysis of molecular function (Fig. S11B
in File S1). Pleurocidin elicited responses both in membrane
components and in the cell itself (Fig. 5; Fig. S12 in File S1) with
biological processes, in particular polysaccharide and macromol-
ecule metabolism and transport, impacted. This was reinforced by
the finding that some 35 genes related to transporter activity were
differentially expressed (Fig. S13 in File S1). These observations
reinforce the view that AMPs impact on bacterial cells in distinct
and AMP-specific ways. When the top 250 genes differentially
expressed in response to challenge with D-LAK120-AP13 were
analyzed, very few enriched pathways were found when biological
processes were considered, with no enriched cellular components
or molecular function identified. This indicates a non-specific
response for this designed peptide notwithstanding its shared
responses with buforin II observed above.
Discussion
The value of a combined approach
When taken together, the metabolomic, electron microscopy
and transcript profiling analyses reveal a combination of generic
and specific responses to challenge with AMPs that share many
physicochemical features but that differ in their modes of action.
All four peptides used were cationic, of similar lengths, and will
Figure 4. Transcript profiles and role of individual genes in response to AMP challenge. Four way Venn diagram (A) showing the
distribution of differentially expressed genes detected by the GeneChip E. coli Genome 2.0 Array (p#0.05) following challenge of stationary phase E.
coli NCTC 9001 with each of four AMPs at sub-inhibitory concentrations known to elicit a bacterial response; pleurocidin at 62.5 mg/ml, magainin 2 at
125 mg/ml, D-LAK120-AP13 at 15.6 mg/ml and buforin II at 250 mg/ml. The entries in the Venn correspond to the number of affected genes. Effect on
sensitivity of E. coli BW25113 to magainin 2, pleurocidin and LL-37 of mutations in four of six genes commonly regulated in response to AMPs of
natural origin (B).
doi:10.1371/journal.ppat.1004104.g004
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adopt conformations with secondary amphipathicity in the
supposed target of the E. coli inner membrane. For the analytical
techniques used, some strengths and weaknesses were identified, so
underscoring the value of a combined approach. The electron
micrographs provided compelling evidence of AMPs induction of
manifestly different responses in E. coli challenged at both
inhibitory and sub-inhibitory concentrations. The images however
provide only circumstantial evidence as to the mechanism of
action of each peptide. Instead, quantitative information or details
of the molecular mechanisms involved are needed to pinpoint how
each peptide operates. Transcript profiling provides a rich vein of
information on the bacterial response. The individual gene
products implicated have suggested a wide range of experiments
that will illuminate further how bacteria attempt to fight off
challenges posed by AMPs. Transcript profiling may also be more
sensitive than the other approaches used since it alone was able to
identify a significant response to buforin II which, even when
administered at 250 mg/ml did not cause any perceived effect on
either the internal or external cellular morphology or register a
response as detected by 1H HR-MAS NMR. The transcript
Figure 5. Multi GOEAST comparison of gene ontology (GO) terms relating to cellular component for differential gene responses in
stationary phase E. coli NCTC 9001. Challenge was induced with sub-inhibitory concentrations of pleurocidin (red: p1), magainin 2 (blue: p2) and
buforin II (green: p3). Red arrows represent relationships between two enriched GO terms, black arrows between enriched and un-enriched terms and
black dashed arrows represent relationships between two un-enriched GO terms. Raw p values for GO terms have been adjusted using the Benjamini-
Hochberg method allowing FDR,15%.
doi:10.1371/journal.ppat.1004104.g005
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profiling method remains expensive however and the consumable
costs per sample make its use in a high throughput manner
unattractive. The NMR metabolomic technique has the advantage
of having low per sample consumable costs which enables a much
greater range of test conditions to be assessed. NMR metabolomics
is also highly reproducible and provides quantitative information
on this greater number of test conditions. It would therefore be
attractive to consider whether it could be used as a standalone
method for interrogating bacterial responses to challenge. In the
present study however, while both generic and specific changes in
metabolites were identified in response to AMP challenge, generic
changes may appear overestimated when compared with the
information provided by transcript profiling or micrographs. This
may be due to common metabolic pathways underpinning a series
of distinct bacterial responses and a much larger scale investiga-
tion, with a larger panel of both distinct and more closely related
AMPs is now warranted. This would allow greater weight to be
afforded to certain key metabolites, known to be altered in
response to a given class of AMP with known influence on
bacterial stress responses.
Life and death at the membrane?
This study investigates whether studying bacterial responses,
when challenged with carefully defined sub-lethal concentrations
of antibiotic, provides a detailed systems wide view of the
mechanism of action. The mechanism of action of cationic
amphipathic helix forming antimicrobial peptides has received
considerable attention in the past two decades with much work
focussed on the pore forming activity of magainin 2 and related
peptides [35]. Considered an archetypal pore forming peptide,
there is nevertheless evidence that for at least one microbial target,
Saccharomyces cerevisiae, magainin 2 can enter the cell and interfere
with DNA integrity [36] while pore forming activity that causes
graded dye release is linked to a mechanism that involves
translocation of the peptide across the membrane [37]. Finally,
MD simulations have shown that magainin-H2, when forming a
disordered toroidal pore does indeed translocate to the internal
leaflet of the membrane [38]. Set against these studies are a range
of data on the structurally and physico-chemically related, but
considerably more potent, pleurocidin which is known to have
pore forming activity [21] but is also capable of entering bacteria
to interfere with the synthesis of macromolecules [22]. We have
recently solved the high resolution structures of both magainin 2
and pleurocidin in the anionic detergent SDS (PDB entries 2LSA
and 2LS9 respectively) and found similar regions of flexibility
around the glycine residues in the middle section of the sequence
(Gly 13/18 – magainin 2; Gly 13/17 – pleurocidin). Only in the
membranes that most closely mimic the inner membrane of
Gram-negative bacteria are any differences between the two
peptides observed; here pleurocidin adopts a notably more
disordered conformation under these conditions [18]. The more
disordered conformation of pleurocidin in the E. coli target
membrane may be related to possible pore formation [39] or the
proposed intracellular targeting strategy [22] which, in both cases,
would serve to boost its potency.
Previous ‘omics based studies comparing AMPs action in Gram-
positive bacterial species found that there was very little overlap in
response between Streptococcus pneumoniae that had been challenged
with each of three rather different antimicrobial peptides [11],
while two earlier studies [9,10], which focussed on peptides with
the plasma membrane as a presumed common target, found
rather more overlap. We therefore decided to test whether a more
holistic approach would succeed in discriminating between the
different modes of actions of magainin 2 and pleurocidin and place
their differing membrane activities in a wider context, enabling a
more sophisticated understanding of their respective mechanisms
of action while explaining the greater potency of pleurocidin. In
the present study, the combined approach was readily capable of
distinguishing pleurocidin and magainin 2 on the basis of the
bacterial responses observed in their metabolomic and transcript
profiles with electron micrographs bringing these differences into
sharp relief. Despite the shared physicochemical properties and
conformational propensities of the two peptides and presumed
initial target of the bacterial inner membrane, transcript profiling
identified only 19 genes whose differential expression was common
to both AMP challenges, with differential expression of some 399
genes being a specific response to either pleurocidin or magainin 2.
The E. coli response to AMP challenge is therefore highly
adaptable and is most sensitive to the differing bactericidal
strategies of each peptide. Large scale changes in the internal
morphology of E. coli, following challenge with sub-inhibitory
concentrations of each AMP, provides circumstantial evidence
that both magainin 2 and pleurocidin can enter Gram-negative
bacteria, with the more profound effects of pleurocidin suggesting
a greater proficiency. Improvements in imaging technologies and
labelling techniques may open the way, in future, for the more
precise localisation of both peptides but it is apparent that a simple
description of AMP bactericidal mechanisms that rests solely on
studying the membrane interaction in isolation is inadequate. This
is particularly relevant for the goal of increasing potency.
We have also studied the structural properties of buforin II
which is considered to operate via an intracellular targeting
strategy [18]. Buforin II has a greater affinity for nucleic acids, has
a greater nominal charge at +7 and is less hydrophobic. The
proline kink in buforin II is known to be crucial for enabling
translocation into the E. coli cytosol [24]. Notably, in all
membranes that we have studied, the peptide adopts an extended
helical conformation, rather than one rich in a-helix, and has only
barely detectable antibacterial activity against planktonic E. coli
cultures [18]. We therefore included buforin II in the present study
since we hypothesised that the bacterial response to this peptide
would highlight responses to pleurocidin that are related to an
intracellular targeting strategy. Neither the NMR metabolomic
nor electron micrograph studies though identified a strong
response to even very elevated concentrations of this peptide;
consistent with our previous work which identified only a very
weak effect against planktonic cultures of either E. coli or P.
aeruginosa [18]. Nevertheless, a large number of significantly
differentially expressed genes in response to buforin II challenge
were detected by transcript profiling. While around 64 differen-
tially expressed genes were detected in common to challenge with
buforin II and pleurocidin, 33 differentially expressed genes were
common to buforin II and magainin 2 with a further 534
differentially expressed genes identified that were not affected by
either magainin 2 or pleurocidin. Only six differentially expressed
genes were identified as a common response to these three AMPs.
This further emphasises the plasticity of the E. coli response and
indicates that bacteria have a large repertoire of responses to
challenges.
Considering the ontology of the differentially expressed genes
can suggest how each individual AMP operates but, when used in
comparison, as here, the relative importance of the properties of
each AMP is revealed and supported the view that these three
peptides adopt distinct bactericidal strategies. The ontological
profiles reveal near orthogonal changes in transcript profiles
following sub-lethal challenge with the three different AMPs of
natural origin. Comparison of GO terms with existing paradigms
for the mode of action of each AMP supports the view that the
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present, combined approach faithfully reveals the mechanism of
action, notwithstanding the extra detail that identifies a range of
effects that may contribute to bacterial cell death. In particular, the
identification of eight GO terms linked to membranes supports the
established view that magainin 2 largely acts on the plasma
membrane of Gram-negative bacteria. In contrast, within the top
200 differentially expressed genes, no membrane GO terms were
linked to the action of buforin II which is considered to seek
intracellular targets. This is further supported by the distribution
of GO terms since the effect on binding and a host of biosynthetic
pathways is acute. For pleurocidin, where multiple bactericidal
mechanisms have been proposed, there is substantial overlap
between the cellular component GO terms with those affected by
magainin 2. This indicates that the bacterial membrane is indeed a
common target. However, in contrast with magainin 2, pleur-
ocidin impacts on a large number of intracellular biological
process, in particular macromolecule metabolic and transport
processes. This strongly indicates a multifaceted antibacterial
strategy underpins the high antibacterial potency of this AMP.
Can understanding the bacterial response be exploited
to improve AMP potency?
The high plasticity of the bacterial response to AMP challenge
suggests that deletion of one gene is unlikely to have a great impact
on sensitivity. This view is supported by the study of mutants
identified by mapping metabolite changes with the greatest
pathway impact onto their respective pathways and further work
will be required to more effectively disrupt such pathways in order
to identify any relationship with sensitivity to AMPs.
Nevertheless, six gene products were identified that were
significantly and uniformly affected by the three AMPs derived
from natural sources. Of these six genes, two were down-regulated;
yrdB an anionic 85 amino acid hypothetical protein and yejF. The
yejF gene codes for the ATPase in the ABC transporter YejABEF
which, when mutated, confers resistance to microcin C [33]. The
speculated role of YejABEF as a nickel transporter has been
questioned as it is phylogenetically distant from other oligopeptide
transporters [33]. However, since yejF is down-regulated in the
present study in response to all three peptides obtained from
natural sources and its deletion renders E. coli more sensitive to
both magainin 2 and LL-37, this behaviour does support the
earlier finding that the activity of this protein can have a
considerable effect on peptide antibiotic potency. Indeed, while
mutations in yejABEF confer resistance to microcin C in E. coli,
deletion of yejF in Salmonella enterica increased sensitivity to AMPs,
including both human beta defensins 1 and 2 (hBD-1 and hBD-2)
[40].
Of the four genes that are up-regulated, cysE and manA are
widely distributed amongst taxa, including animals, making them
less attractive as an antibiotic target. In contrast, with a
distribution that is concentrated in Enterobacteriaceae and with yet
to be tested functions, yohN and yjjB might be more attractive
targets for further investigation and possible targets for adjuvants
that could boost the potency of the host innate immune response.
Deletion of these genes caused a significant but only modest
increase in sensitivity to magainin 2 and LL-37 while the potency
of pleurocidin was unaffected. These results show that the
combined systems approach is indeed capable of identifying genes
that regulate resistance/sensitivity in E. coli but that the large
number of potentially differentially expressed genes at the disposal
of such bacteria will mitigate the effect that silencing one gene
product may have.
Finally, we were interested to contrast the expected results for
the three peptides representing naturally occurring AMPs with the
bacterial response to a peptide, D-LAK120-AP13, which was
composed of D-amino acids only. D-LAK120-AP13 was designed
in an attempt to circumvent the effect of proteases secreted by
target pathogens, and incorporate structural features, including
high cationicity and propensity for adopting a-helix rich
conformation [41] - and hence inserting into and disordering
the E. coli inner membrane - and a proline kink, affording
conformational flexibility [20] that facilitates penetration into
bacteria [23,24]. The robust and potent effect of this peptide
against E. coli was evident with a significant metabolomic
response even at very low peptide concentrations. Circumstantial
evidence for the ability to penetrate within bacterial cells was
shown by transmission electron microscopy, with the most
profound changes due to challenge with any of the four AMPs
observed, and transcript profiling. Again underlining the plastic-
ity of the E. coli response, transcript profiling identifies a further
390 differentially expressed genes that were uniquely affected by
D-LAK120-AP13 although, interestingly, there is considerable
degree of overlap with the response to buforin II with 192
differentially expressed genes in common. These two peptides
have a greater nominal cationic charge in solution at neutral pH
than either pleurocidin or magainin 2 and both incorporate a
proline induced kink in the secondary amphipathic conformation.
Taken together, the data support highly effective entry of D-
LAK120-AP13 into Gram-negative bacterial cells and it is this
that may underpin its high antibacterial potency.
With four distinct but physicochemically related AMPs now
tested by an integrated systems biology approach, a total of at least
1342 differentially expressed genes (p#0.05) have been identified
as being potential tools that can be manipulated by the bacteria to
overcome AMP challenge. This is equivalent to between 24 and
32% of the total E. coli genome and suggests, with more
structurally diverse AMPs yet to be tested, that bacteria have a
wide variety of means of overcoming AMP challenges. Under-
standing these responses enables both the mode of action of AMPs
to be elucidated as well as suggesting strategies to overcome these
defences. The approach may find generic applicability in the study
of antibiotic-bacteria arms races.
Materials and Methods
Materials
The peptides (Table 1) were all amidated at the C-terminus and
were purchased from Pepceuticals Ltd (Nottingham, UK) as
desalted grade or synthesised in house (D-LAK120-AP13) and
were further purified using water/acetonitrile gradients using a
Waters SymmetryPrep C8, 7 mm, 196300 mm column.
Bacterial culture and challenge
Cultures of Escherichia coli NCTC 9001, a strain isolated from a
patient with cystitis, were grown overnight in Mueller-Hinton
broth (MH) at 37uC. Once the OD620 reached<1.0, 1 ml aliquots
of bacterial suspension were transferred into 1.5 ml microcen-
trifuge tubes and aqueous solutions of peptides - magainin 2,
buforin II, pleurocidin and D-LAK120-AP13 were added at the
following concentrations: 250 mg/ml, 125 mg/ml, 62.5 mg/ml,
15.6 mg/ml, 3.9 mg/ml and incubated for 30 min at 37uC. In
order to be able to monitor the microbial recovery and growth,
10 ml of each suspension was sampled in 190 ml fresh medium onto
a 96-well microplate. The OD620 was measured at time 0 and after
4 h of incubation at 37uC. The microcentrifuge tubes were
centrifuged at 50006 g for 5 min and the bacterial pellets were
snap frozen in liquid nitrogen, lyophilised and kept at 220uC until
further use. Pellets from triplicate tubes were combined for
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subsequent HR-MAS analysis. Each challenge was independently
repeated nine times.
HR-MAS NMR
High-resolution magic angle spinning (HR-MAS) experiments
were performed on a Bruker Avance 400 MHz spectrometer
equipped with a 4 mm 1H/13C HR-MAS probe. The lyophilised
cell pellets were thawed at room temperature, transferred to an
NMR rotor inserts and rehydrated with 30 ml of D2O 2 hours
before the acquisition. 1D spectra were recorded at a constant
temperature of 310 K with magic angle spinning applied at 5 kHz.
1D 1H spectra were recorded using a standard cpmgpr1d spin
echo pulse (cpmgpr; Bruker) with water presaturation during
recycle delay of 1 second and a total of 128 scans were acquired.
The spectral width was 16.02 ppm and 1H 90 pulse length was
7.81 msec. The free induction decay was multiplied with an
exponential function corresponding to a line broadening of
0.3 Hz. Phase correction was performed manually and automatic
baseline correction was applied. A total of 120 samples were
analysed with between 6 and 13 samples per treated condition and
17 control samples (no AMP treatment). A number of 2D
experiments were run to facilitate identification of the compounds:
homonuclear J-resolved 2D correlation with presaturation during
relaxation delay using gradients (J-Res; jresgpprqf), 1H/13C
correlation via direct inept transfer, phase sensitive using states,
with decoupling during acquisition (HSQC 13C; AA-hsqcwg-
13C), 2D homonuclear shift correlation with presaturation during
relaxation delay (COSY; cosyprqf) all acquired using standard
Bruker pulse sequences. Spectra were Fourier transformed,
manually phase and automatically baseline corrected and
calibrated with 2,2,3,3-D4-3-(Trimethylsilyl) propionic acid sodi-
um salt (TMSP-2,2,3,3-D4) with reference signal at 0 ppm.
Assignment
Resonances were assigned based on J-couplings partners
revealed by COSY, multiplicities derived from J-Res, statistical
correlation spectroscopy (STOCSY) [42] and both 1H and 13C
chemical shifts with reference to the E. coli metabolome database
[43].
Multivariate data analysis
Spectra were analysed by principal component analysis (PCA)
and orthogonal partial least squares discriminant analysis (OPLS-
DA) using software developed in our laboratory for a previous
study [44] incorporating the nonlinear iterative partial least
squares (NIPALS) algorithm [45]. First, the spectra were aligned
to the reference peak and spectral regions such as water and
reference peak (4.8 ppm and 0 ppm, respectively) and regions of
no interest and/or no spectral information were removed. Spectra
were then normalised using probabilistic quotient normalization
(PQN) [46] and autoscaled but not bucketed. Cross-validation was
performed where 66% of the samples were used as a training set
and the remaining 33% as a test set, ensuring that the number of
samples in the test set was proportional to the total number of
samples from each class, and that at least one sample from each
class was present in the test set. To choose the number of
components for the model, a leave-one-out cross-validation was
carried out on the samples in the training set, and the F1-score
used to choose the number of components, with the additional
constraint to use a maximum of 10 components. This double
cross-validation was repeated 2000 times with randomly chosen
samples in the training and test set to prevent bias due to the
choice of training or test set. This leads to 362000 models (in the
supplementary information, each of these models leads to a point
on the scores plot, but loadings and weights are presented as
averages over all these models). Finally, this procedure was
repeated with randomly generated class assignments to provide a
reference value for Q2. The chosen number of components minus
one was then used as an OPLS filter and a PLS-DA analysis with
two components was carried out on the filtered data to yield one
predictive and one orthogonal component. The Q2 value was
calculated as Q2= 12(PRESS/TSS) where PRESS is the sum of
squared differences between the known and predicted classes, and
TSS is the sum of squared differences between the known classes
and their average ( = the total variance). Q2 thus gives a measure
of the goodness of fit after cross validation, and although it is
generally considered to be ‘‘good’’ when its value is higher than
0.5 [47,48] we have compared it to a reference value by
computing Q2 for models where the classes were assigned
randomly [47,48]. In each case, genuine or permutated class
assignments, the Q2 value quoted is the mean of all models. Back-
scaled loadings plots [49] were used to identify resonances with
high variance and high weight, therefore the discriminating
resonances, and verified against the peak intensity of the original
spectra after PQN normalisation. Freely available MultiExperi-
ment Viewer (MeV) which is a part of the TM4 Microarray
Software Suite [50] was used for hierarchical cluster (HCL)
analysis and generation of heatmaps. Euclidian distance algorithm
was used to compute the differences between two gene expression
levels (metabolite level changes) and the average linkage method
was used to define the distances.
Scanning and transmission electron microscopy
Both SEM and TEM were used to examine the structural
changes in bacteria induced by AMPs. Samples for the imaging
were prepared in parallel with the samples used for HR-MAS
NMR and hence represent bacteria in stationary phase. For SEM,
the pellet obtained after centrifugation was fixed in 25 ml of 2.5%
(v/v) glutaraldehyde in 0.2 M sodium cacodylate buffer and kept
at 4uC until further use. In 24-well tissue culture plates 20 ml
aliquots of vortexed bacterial pellet was smeared on 12 mm round
poly-L-lysine (BD Biosciences, Bedford) cover slips with adjacent
chambers filled with sufficient amount of 0.2 M sodium cacodylate
to prevent drying of the slides and kept in a hydration chamber for
2 h. Cover slips were then washed with 0.2 M sodium cacodylate
buffer followed by rinsing with 30%, 70%, 100%, 100%, and
100% ethanol and incubating for 10 min between each wash.
Hexamethyldisilazane (HMDS) was used for drying of the
specimen by washing cover slips in 50/50 100% ethanol/HMDS
for 10 min followed by the final wash in HMDS for 10 min. The
coverslips with dehydrated cells were mounted on the specimen
stubs and sputter coated with gold. Micrographs were acquired
with FEI Quanta 200F FEG scanning electron microscope.
Bacterial pellets for TEM processing were prepared as described
above. Cells were pelleted by centrifugation and the pellet was post
fixed in 1% osmium tetroxide in 0.1 M phosphate buffer for
60 min an RT. The pellet was dehydrated by exposure to a graded
series of ethanol (10%, 70% for 10 min each) followed by four
washes in 100% ethanol for 15 min each. Next, the pellet was
subjected to two washes in propylene oxide, 10 min each. Tubes
containing pellets were constantly rotated during the washes and
the following procedures and the washes were performed in the
fume hood. The supernatant was removed and the pellet placed
into a mixture of 50% resin and propylene oxide for 90 min and
transferred to 100% resin overnight before polymerisation at 60uC
for 24 hours. The resin blocks were sectioned with Leica Ultra-cut
ultramicrotome to semi-thick sections (0.75 mm–2 mm) and stained
with toluidine blue and used to determine the areas for thin
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sectioning (90 nm). The sections were then placed onto 150 mesh
copper grids coated with pioloform support film. Grids were then
stained with uranyl acetate and lead citrate before viewing on
Hitachi H7600 transmission electron microscope. For both
techniques, around 15 images were taken for each treatment.
The following magnifications were used and images were selected
that are representative of the effect observed: 7006, 50006,
120006, 250006, 700006.
GeneChips
GeneChip experiments were performed using the Affymetrix
(Santa Clara, CA) E. coli Genome 2.0 Array with effective,
response inducing, sub-MIC AMP concentrations determined
from the HR-MAS metabolomic study; pleurocidin 62.5 mg/ml,
buforin II 250 mg/ml, magainin 2 125 mg/ml and D-LAK120-
AP13 15.6 mg/ml. Each array includes approximately 10,000
probe sets for all 20,366 genes present in four strains of E. coli over
the entire open reading frame (ORF); K12 (MG1655 laboratory
strain), CFT073 (uropathogenic), 0157:H7-EDL953 (enteropatho-
genic) and O157:H7-Sakai (enteropathogenic). RNA was extract-
ed using RiboPure and enriched using MICROBExpress Bacterial
mRNA Enrichment Kit after the DNA digestion step (Life
Technologies, Paisley, UK) At each step the quality of RNA was
assessed using Pico100 (Picodrop Ltd, Hinxton, UK). cDNA was
synthesized from mRNA and purified using Qiagen MinElute
PCR (Qiagen, Manchester, UK). cDNA was then fragmented and
labeled using terminal transferase and biotinylated Affymerix
GeneChip labelling reagent according to the manufacturer’s
instructions. Fragmentation and labeling were assessed with the
2100 Bioanalyzer (Agilent Technologies, Wokingham, UK) to
obtain the size distribution and yield. cDNA was kept at 280uC
until microarray hybridization. Hybridization of the target to the
GeneChip was prepared according the standard Prokaryotic
Target Hybridisation protocol according to the manufacturer’s
instructions. The efficiency of the hybridization step was assessed
by examining hybridization of Poly-A controls provided for the
Affymetrix GeneChip. Arrays were scanned on an Affymetrix
GCS3000 microarray system and image acquisition, quantification
and data analysis were performed using Affymetrix Command and
Expression Console Software. Data were normalized using the
Robust Multi-array Average (RMA) algorithm built into Expres-
sion Console. Pre-selection of gene lists for each treatment was
performed using Qlucore Omics Explorer (Qlucore AB, Lund,
Sweden). First, ANOVA across all samples identified the twenty
most differentially expressed genes according to each replicated
treatment. These were then assessed by principal component
analysis (Fig. S6 in File S1) to confirm that independently
replicated experiments produced consistent results. Signal inten-
sities for gene expression were then averaged across technical
duplicates/triplicates and log transformed. For the gene annota-
tion enrichment analysis, differentially expressed genes in treat-
ment versus control samples were selected by a paired, homosce-
dastic t-test with a significance cutoff of p,0.05 and lists for the
four AMP treatments were then compared using Venny [51].
Microarray data are available in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) under accession number E-MTAB-1703.
To better understand the differences between the effects of the
four treatments, significance thresholds that identified the
approximate top 200–250 differentially expressed genes were
selected; p#0.0184 for buforin II and D-LAK120-AP13,
p#0.0425 for pleurocidin and p#0.078 for magainin 2. These
lists were analyzed using the GOEAST Gene Ontology Enrich-
ment Analysis Software Toolkit where the Benjamini-Hochberg
option was selected allowing an FDR up to 15% [52].
Discriminating metabolite changes, identified from HR-MAS
NMR, were then mapped onto the KEGG pathway using BioCyc
Omics Data Analysis [53] and genes related to given metabolic
pathway checked against consistently differentially expressed
genes, whether or not they had passed the significance test
described above.
Multiparameter viability assays
In order to assess the functionality and cellular integrity of
bacteria we used the following viability assays: membrane
potential assay, esterase activity assay and BacLight Live-Dead
stain for microscopy [26].
As previously, E. coli NCTC 9001 were grown from glycerol
stocks in Muller-Hinton broth overnight at 37uC without shaking
until an OD620 of 1.0 was reached. 1 ml aliquots of culture were
challenged for 30 min with four peptides at and below the
threshold concentrations established with NMR. Cells were then
harvested by centrifugation at 5,0006 g for 5 min and washed in
50 mM phosphate buffer (pH 7.0). For BacLight Live/Dead stain
cells were diluted to 46108 CFU/ml, whereas for the remaining
assays cells were diluted to 26108 CFU/ml. All experiments were
performed at room temperature. Negative controls were obtained
either by treatment with 70% isopropanol for 10 min and
removed by centrifugation at 5,0006 g for 5 min and re-
suspension in PBS, or by heat killing at 85uC for 10 min on a
heat block. Assays were performed in black, flat bottom, 96-well
plates and read on a Synergy HT multi-mode microplate reader
(BioTek, Winooski, VT)
Membrane potential
25 mg of dye DiBAC4 (Anaspec, Fremont, CA) was reconsti-
tuted in 2.42 ml ethanol to obtain a 20 mM stock solution which
was stored at 220uC. The stock was diluted further with water to
working concentration of 12.5 mM immediately before use. 20 ml
of 12.5 mM dye was added to a 96-well plate, covered by 180 ml
bacterial suspension in PBS and mixed. The plate was incubated
in the dark for 5 minutes and fluorescence emission was measured
(excitation 485 nm, emission 535 nm). Since membrane damage
leads to higher fluorescence intensity, values were background
corrected and expressed as a reciprocal before being normalised
with untreated cells defined as being 100% and isopropanol
treated cells defined as 0%.
Esterase activity
5 mg of esterase substrate 5,6-carboxyfluorescein diacetate
(CFDA) was dissolved in 1.086 ml dimethyl sulfoxide (DMSO)
to obtain 10 mM stock kept at 220uC. Stock was diluted 406 in
water immediately before use to obtain working concentration of
250 mM, which was pre-aliquoted to a 96-well plate. 180 ml of
bacterial suspension in PBS was added to the plate and mixed with
the detection solution. The plate was incubated in dark for
30 minutes with occasional shaking and fluorescence emission
measured (excitation 485 nm, emission 535 nm).
LIVE/DEAD BacLight
LIVE/DEAD BacLight kit (Life Technologies, Paisley, UK) was
used to measure membrane integrity. Harvested cells were
reconstituted with saline and 3 ml of the dye mixture (1.5 ml of
SYTO9 (3.34 mM) and 1.5 ml of propidium iodine (20 mM)) was
added to each 1 ml of bacterial suspension and mixed. Tubes were
incubated for 15 minutes in the dark with occasional shaking and
fixed with 20% paraformaldehyde (PFA) and kept at 4uC.
Specimens were viewed on an Olympus BX60 microscope fitted
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with an Andor Ultrahigh-resolution CCD setup. A 620 oil
immersion lens was used to obtain a 200 mm field width.
Excitation and emission filters were 480/520 nm and 515/
560 nm respectively.
MIC testing
Parent strain BW25113 and Keio knockout strains [34] for
DyejF, DyjjB, DyohN, and DyrdB were obtained from the Coli
Genetic Stock Center (Yale University, New Haven, CT). The
activities of the peptides were assessed in planktonic suspension in
polypropylene 96 well plates (Greiner Bio-one, Frickhausen,
Germany) according to a modified broth dilution assay (54).
Bacteria were grown without shaking in 50 ml Mueller-Hinton
(MH) broth at 37uC. Peptides (pleurocidin, magainin 2 and LL-37)
were tested in duplicates with two rows allocated for each peptide.
In each of columns 2–11, 50 ml of MH broth was added under
sterile conditions. In the first column of each row, 50 ml of 256 mg/
ml stock peptide solutions, prepared in distilled water, were added
and then the broth from the second column was pipetted into the
first column and thoroughly mixed before being deposited again in
the second column. This process was repeated throughout the tray
providing a twofold dilution of peptide with each row. Bacteria
with an A620 of 0.001 were then added to each well in volumes of
50 ml giving a further twofold dilution and a final volume of 100 ml
per well. The final column was used either as sterility control
(100 ml broth) or negative control (no peptide). Plates were
incubated overnight at 37uC and the A620 read. Growth curves
prepared from duplicates were fitted to determine the peptide
concentration required to inhibit growth by 50% (MIC50). The
MIC50 quoted for each peptide (Fig. 4) is an average value from at
least two independent repeats.
Supporting Information
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